NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Guideline Centre (UK). Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. London: National Institute for Health and Care Excellence (NICE); 2018 Mar. (NICE Guideline, No. 89.)
December 2019: In recommendation 1.3.5 the British Standards for anti-embolism hosiery were updated because BS 6612 and BS 7672 have been withdrawn. August 2019: Recommendation 1.12.11 (1.5.30 in this document) was amended to clarify when anti-embolism stockings can be used for VTE prophylaxis for people with spinal injury.
Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism.
Show detailsJ.1. Risk assessment for medical, surgical and trauma patients
J.1.1. Accuracy of risk assessment tools for VTE in hospital admissions
No relevant economic evaluations were identified.
J.1.2. Accuracy of risk assessment tools for bleeding in hospital admissions
No relevant economic evaluations were identified.
J.1.3. Effectiveness of risk assessment tools in hospital admissions
Download PDF (517K)
J.2. Risk assessment for people having day procedures
J.2.1. Accuracy of risk assessment tools for VTE for day procedures
No relevant economic evaluations were identified.
J.2.2. Accuracy of risk assessment tools for bleeding for day procedures
No relevant economic evaluations were identified.
J.2.3. Effectiveness of risk assessment tools for day procedures
No relevant economic evaluations were identified.
J.3. Reassessment of VTE and bleeding risk
J.3.1. Reassessment of risk for hospital admissions
No relevant economic evaluations were identified.
J.3.2. Reassessment of risk for day procedures
No relevant economic evaluations were identified.
J.4. Risk assessment for pregnant women and women up to 6 weeks postpartum
No relevant economic evaluations were identified.
J.5. Giving information to patients and planning for discharge
No relevant economic evaluations were identified.
J.6. General VTE prevention for everyone in hospital
No relevant economic evaluations were identified.
J.7. Nursing care: Early mobilisation and hydration
No relevant economic evaluations were identified.
J.8. Obesity
No relevant economic evaluations were identified.
J.9. People using antiplatelets
No relevant economic evaluations were identified.
J.10. People using anticoagulation therapy
No relevant economic evaluations were identified.
J.11. Acute coronary syndromes
No relevant economic evaluations were identified.
J.12. Acute stroke patients
Download PDF (471K)
J.13. Acutely ill medical patients
Download PDF (543K)
J.14. Cancer
Download PDF (463K)
J.15. Patients with central venous catheters
No relevant economic evaluations were identified.
J.16. Palliative care
No relevant economic evaluations were identified.
J.17. Critical care
No relevant economic evaluations were identified.
J.18. Pregnant women and women up to 6 weeks postpartum
No relevant economic evaluations were identified.
J.19. People with psychiatric illness
No relevant economic evaluations were identified.
J.20. Anaesthesia
No relevant economic evaluations were identified.
J.21. Lower limb immobilisation
No relevant economic evaluations were identified.
J.22. Fragility fractures of the pelvis, hip and proximal femur
Download PDF (512K)
J.23. Elective hip replacement
No relevant economic evaluations were identified.
J.24. Elective knee replacement
No relevant economic evaluations were identified.
J.25. Non-arthroplasty orthopaedic knee surgery
No relevant economic evaluations were identified.
J.26. Foot and ankle orthopaedic surgery
No relevant economic studies were identified.
J.27. Upper limb orthopaedic surgery
No relevant health economic studies were identified.
J.28. Spinal surgery
No relevant health economic studies were identified.
J.29. Cranial surgery
No relevant health economic studies were identified.
J.30. Spinal injury
No relevant health economic studies were identified.
J.31. Major trauma
Download PDF (528K)
J.32. Abdominal surgery (excluding bariatric surgery)
Download PDF (631K)
J.33. Bariatric surgery
Download PDF (501K)
J.34. Cardiac surgery
No relevant health economic studies were identified.
J.35. Thoracic surgery
Download PDF (528K)
J.36. Vascular surgery
No relevant economic studies were identified.
J.37. Head and neck surgery
J.37.1. Oral and maxillofacial surgery
No relevant economic studies were identified.
J.37.2. Ear, nose and throat (ENT) surgery
No relevant economic studies were identified.
- Risk assessment for medical, surgical and trauma patients
- Risk assessment for people having day procedures
- Reassessment of VTE and bleeding risk
- Risk assessment for pregnant women and women up to 6 weeks postpartum
- Giving information to patients and planning for discharge
- General VTE prevention for everyone in hospital
- Nursing care: Early mobilisation and hydration
- Obesity
- People using antiplatelets
- People using anticoagulation therapy
- Acute coronary syndromes
- Acute stroke patients
- Acutely ill medical patients
- Cancer
- Patients with central venous catheters
- Palliative care
- Critical care
- Pregnant women and women up to 6 weeks postpartum
- People with psychiatric illness
- Anaesthesia
- Lower limb immobilisation
- Fragility fractures of the pelvis, hip and proximal femur
- Elective hip replacement
- Elective knee replacement
- Non-arthroplasty orthopaedic knee surgery
- Foot and ankle orthopaedic surgery
- Upper limb orthopaedic surgery
- Spinal surgery
- Cranial surgery
- Spinal injury
- Major trauma
- Abdominal surgery (excluding bariatric surgery)
- Bariatric surgery
- Cardiac surgery
- Thoracic surgery
- Vascular surgery
- Head and neck surgery
- Health economic evidence tables - Venous thromboembolism in over 16sHealth economic evidence tables - Venous thromboembolism in over 16s
Your browsing activity is empty.
Activity recording is turned off.
See more...